Health ❯Healthcare ❯Pharmaceuticals ❯Drug Approval

FDA Approval

Clinical Trials Pharmaceuticals Patient Care Drug Approval Drug Development Patient Support Market Impact Research Studies Market Analysis Public Health

3 ARTICLES

last mo.

Sotatercept cuts risk of death and hospitalization by 76% in advanced pulmonary arterial hypertension

Published in The New England Journal of Medicine on May 28, the Zenith trial marks the first demonstration of a survival benefit for sotatercept in late-stage pulmonary arterial hypertension

4 ARTICLES

3mo ago

FDA Approves VYKAT XR, First Therapy for Hyperphagia in Prader-Willi Syndrome

37 ARTICLES

5mo ago

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

15 ARTICLES

5mo ago

FDA Approves First Nasal Spray for Treatment-Resistant Depression